Table I. S100A7 and S100A15 transcript expression in invasive carcinomas.

Relative transcript levels of hS100A7 and hS100A15-L (long isoform) in invasive breast carcinomas

#	case	a hS100A7	b S100A15-L	c ER	d PR
1	13895	4	4	neg	neg
*2	15608	4	2	neg	neg
3	14664	3	4	neg	neg
*4	14177	4	2	neg	neg
5	15021	2	3	neg	neg
6	14744	2	2	neg	neg
7	14232	2	1	neg	neg
*8	13551	2	2	neg	neg
*9	13840	2	3	neg	neg
10	15170	2	2	neg	pos
11	11186	1	1	pos	neg
12	11429	1	1	pos	pos
13	11945	1	1	pos	neg
*14	12502	1	1	pos	neg
*15	12661	1	1	pos	neg
16	13212	1	1	pos	pos
17	13642	1	1	pos	neg
*18	13884	1	1	pos	pos
19	13918	2	1	pos	neg
*20	14753	1	1	pos	pos

^ahS100A7 expression by qRT-PCR relative to hGAPDH (1: ≤ 10, 2: >10-2000, 3: >2000-10.000, 4: >10000)

^bhS100A15-long transcript expression by qRT-PCR PCR relative to hGAPDH (1: ≤ 10, 2: >10-200, 3: >200-500, 4: >500

^cER −ve >3 fmol/mg protein

^dPR −ve >15 fmol/mg protein

^*confirmed by immunoblot analysis (see Fig 4)